Header Logo

Connection

Mark Britton to Diabetes Mellitus, Type 2

This is a "connection" page, showing publications Mark Britton has written about Diabetes Mellitus, Type 2.
Connection Strength

0.206
  1. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Pharmacotherapy. 2005 Nov; 25(11):1602-20.
    View in: PubMed
    Score: 0.195
  2. Second-generation thiazolidinediones and hepatotoxicity. Ann Pharmacother. 2004 Sep; 38(9):1419-23.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.